Evidence map›Paper›PMID 36570693›Full record

ReviewHemaSphere2023

Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults.

Francesca Fioredda, Carlo Dufour, Petter Höglund, Helen A Papadaki, Jan Palmblad

Open access · goldAbstract readReview
In one paragraph

Review in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Cytopenias in Autoimmune Liver Diseases-A Review.Journal of clinical medicine · 2025
    Review
  8. Secondary Neutropenias.Biomedicines · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Francesca FioreddaUnit of Hematology, IRCCS-Istituto Giannina Gaslini, Genova, Italy.
Carlo DufourUnit of Hematology, IRCCS-Istituto Giannina Gaslini, Genova, Italy.
Petter HöglundDepartments of Medicine, Transfusion Medicine and HERM, The Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Helen A PapadakiHemopoiesis Research Laboratory, School of Medicine, University of Crete, Greece.
Jan PalmbladDepartments of Medicine and Hematology, The Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Istituti di Ricovero e Cura a Carattere Scientifico · ITKarolinska Institutet · SEKarolinska University Hospital · SEUniversity Hospital of Heraklion · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The definition of autoimmune neutropenias (AIN) has been based on the demonstration of autoantibodies directed to various epitopes on blood neutrophils. However, this definition is probably too limited and excludes neutropenias (NPs) with a negative autoantibody test but with other phenomena that indicate an underlying autoimmune process. Examples of such AINs may be complete or incomplete systemic lupus erythematosus or other autoimmune diseases where NP is common but patients may not fulfill formal diagnostic criteria for a rheumatic disease. Recently, various inherited immune-dysregulation syndromes, such as those related to variants in, for example,

Identifiers

PMID36570693
PMCPMC9771305
OpenAlexW4312211662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.